After hacking Trivy, TeamPCP moved to compromise repositories across NPM, Docker Hub, VS Code, and PyPI, stealing over 300GB ...
So, you want to get into Python coding online, huh? It’s a pretty popular language, and luckily, there are tons of tools out ...
The company had clashed with the military over how officials wanted to use its cutting-edge A.I. model. The order could vastly complicate intelligence analysis and defense work. By Julian E. Barnes ...
This study is Pew Research Center’s latest effort to explore the landscape of teens and technology today. It focuses on artificial intelligence – from how teens use chatbots to how they think about AI ...
In mid-December 2025, an image (archived) circulated online purportedly showing U.S. President Donald Trump using a walker as a mobility aid. Keith Edwards, a Democratic political strategist, posted ...
Currently, the Python extension only supports “Run Selection/Line in Native Python REPL”. However, there is no built-in command to run the entire file in the Native Python REPL environment, similar to ...
Anthropic is starting to train its models on new Claude chats. If you’re using the bot and don’t want your chats used as training data, here’s how to opt out. Anthropic is prepared to repurpose ...
Main Street’s not dazzled by AI’s big promises. Small businesses are testing it cautiously, leaning on features tucked into their daily software. A little over a year ago, the U.S. Chamber of Commerce ...
As you’ve probably heard, if not also experienced, AI is reshaping how we work. If you happen to be a senior professional with sufficient reputational capital, status, and a deep social network, you ...
Robin Brewer receives funding from the National Science Foundation and the National Institutes of Health. She has previously received funding from Google, the Retirement Research Foundation, and the U ...
I used to believe I taught the one genre that artificial intelligence couldn’t touch. For 15 years, I’ve guided college students through the deeply human work of personal narrative, helping them ...
Shares of Replimune (NASDAQ:REPL) plunged ~38% in the premarket on Monday after Stat News reported that the FDA’s top regulator of cancer drugs intervened during the review of the company’s lead asset ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results